The Framingham Risk Score is a tool that estimates your chance of developing heart disease or having a cardiovascular event within the next 10 years. It combines several common health measurements, including age, blood pressure, cholesterol levels, smoking status, and whether you have diabetes, into a single percentage that places you into a risk category. Doctors have used it for decades to decide who might benefit from preventive treatments like cholesterol-lowering medications.
How the Score Works
The score uses a formula that weighs several risk factors together, because no single measurement tells the full story of your cardiovascular health. The inputs are: your sex, age, systolic blood pressure (the top number), total cholesterol, HDL cholesterol (the “good” kind), whether you smoke, and whether you have diabetes. Each factor is weighted differently depending on your sex, and the formula produces a percentage representing your 10-year probability of a cardiovascular event.
That percentage is then sorted into a risk category:
- Low: Less than 5%
- Borderline: 5% to 7.4%
- Intermediate: 7.5% to 19.9%
- High: 20% or greater
The “cardiovascular events” it predicts are broad. They include heart attacks, coronary death, angina, ischemic and hemorrhagic stroke, mini-strokes (transient ischemic attacks), peripheral artery disease, and heart failure. The score was validated for adults between the ages of 30 and 74 who don’t already have diagnosed cardiovascular disease.
Where It Came From
The score grew out of the Framingham Heart Study, a landmark research project that began in 1948 in Framingham, Massachusetts. Researchers enrolled 5,209 men and women who were free of heart disease and tracked them over decades. By 1961, Dr. William Kannel and his colleagues published one of the first papers establishing that factors like high blood pressure and cholesterol actually preceded heart disease rather than just appearing alongside it. This was the birth of the concept of “risk factors.”
Early versions of the risk formula, published in 1967, used seven variables including hemoglobin and electrocardiogram findings. Over the following decades, the formula was refined. Hemoglobin was dropped. HDL cholesterol was added in the 1990s, along with an expanded age range up to 74. A point-scoring system was introduced so doctors could calculate risk by hand, and eventually online calculators made the process even faster. By 1998, the formula had been streamlined to the version most clinicians recognize today.
How It Influences Treatment Decisions
Your risk category helps guide conversations about prevention. If you fall in the intermediate or high range, your doctor is more likely to recommend cholesterol-lowering medication. For people in the borderline or intermediate range, additional factors can tip the scales toward treatment: a family history of early heart disease (a father or brother before age 55, or a mother or sister before 65), very high LDL cholesterol, chronic kidney disease, inflammatory conditions like rheumatoid arthritis, or South Asian ancestry.
The score isn’t a diagnosis. It’s a starting point for deciding how aggressively to manage your risk. Someone with a 10-year risk of 22% will likely be approached differently than someone at 4%, even if both people feel perfectly healthy.
Known Limitations
The Framingham Risk Score was developed from a predominantly white, middle-class population in a single New England town, and that narrow origin creates real blind spots. Studies have shown it overestimates coronary risk in many European populations, where background rates of heart disease are lower than in the U.S. More concerning, it underestimates risk in people from lower-income and socioeconomically deprived backgrounds. One British study found the score underpredicted cardiovascular disease by 31% in non-manual workers, and by 48% in manual workers. The underprediction worsened as neighborhood deprivation increased.
This matters because if your predicted risk falls below the threshold for treatment, you won’t be offered preventive medication, even though your actual risk may be considerably higher. Socioeconomic disadvantage increases cardiovascular risk through pathways the score doesn’t capture: chronic stress, limited access to healthy food, environmental exposures, and other factors that don’t show up in a blood pressure reading or cholesterol panel.
The score also performs less accurately in Black populations. Research comparing it to newer tools found that the Framingham score underestimated disease burden in Black individuals classified as “low risk,” missing signs of vascular disease that a different calculator caught. Race remained an independent risk factor even after adjusting for the Framingham score, suggesting the tool doesn’t fully account for the disparities these populations face.
Newer Alternatives
The Framingham Risk Score is no longer the primary tool recommended by major cardiology guidelines. In 2013, the American College of Cardiology and American Heart Association introduced the Pooled Cohort Equations, which estimate 10-year risk of atherosclerotic cardiovascular disease (heart attack and stroke specifically). This calculator was built from more diverse study populations and performed better at predicting risk in Black adults compared to the Framingham score.
More recently, in 2024, the American Heart Association released the PREVENT calculator, which represents a significant shift. Developed using data from more than 6 million adults across diverse racial, ethnic, socioeconomic, and geographic backgrounds, it estimates risk over both 10 and 30 years. For the first time, it incorporates kidney and metabolic health alongside traditional cardiovascular measures, and it adds heart failure as a predicted outcome. The PREVENT equations are sex-specific and deliberately race-free, reflecting the scientific consensus that race is a social construct rather than a biological variable that belongs in a risk formula. It can also incorporate a social determinants of health index.
Despite these newer tools, the Framingham Risk Score remains widely referenced in research and clinical practice around the world. Many international guidelines still use it or adaptations of it, and its simplicity makes it practical in settings where more complex calculators aren’t available. If your doctor mentions your “10-year cardiovascular risk,” they may be using the Framingham formula, the Pooled Cohort Equations, or the PREVENT calculator, so it’s worth asking which one.